Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
173M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
18.6M
-
Shares change
-
-697K
-
Total reported value, excl. options
-
$21.4M
-
Value change
-
-$736K
-
Number of buys
-
24
-
Number of sells
-
-28
-
Price
-
$1.15
Significant Holders of Savara Inc - Common Stock, par value $0.001 per share (SVRA) as of Q4 2020
73 filings reported holding SVRA - Savara Inc - Common Stock, par value $0.001 per share as of Q4 2020.
Savara Inc - Common Stock, par value $0.001 per share (SVRA) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.6M shares
of 173M outstanding shares and own 10.8% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (5.13M shares), FARALLON CAPITAL MANAGEMENT LLC (4.45M shares), AXA S.A. (1.9M shares), VANGUARD GROUP INC (1.76M shares), STATE STREET CORP (709K shares), GEODE CAPITAL MANAGEMENT, LLC (580K shares), NORTHERN TRUST CORP (505K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (400K shares), RENAISSANCE TECHNOLOGIES LLC (400K shares), and Woodline Partners LP (375K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.